Abdominal Aortic Aneurysm Repair Devices Market
Growth Analysis By Top Players
Abdominal Aortic Aneurysm (AAA) refers to the enlargement in part of the aorta, the main
blood vessel that delivers blood to the body, which passes through the abdomen. AAA usually
affects people over 50 years and is more common in men as compared to women. Others risk
such as smoking and high blood pressure can also cause AAA. Previously, AAA was treated
with open surgery, however, it has been replaced with endovascular stent grafting.
Endovascular stent grafting is a minimally invasive procedure and has various advantages over
open surgery such as reduced blood loss, operative time, hospital stay, mortality, and
morbidity.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1568
Abdominal Aortic Aneurysm Repair Devices Market Drivers
Key players in the abdominal aortic aneurysm repair devices market have launched various new
products for AAA treatment and this has positively affected growth of the market. For instance,
in 2017, Lombard Medical Inc. received approval from the Japanese Ministry of Health, Labour
and Welfare for its new IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular
Stent Graft. In 2016, Lombard Medical, Inc. received CE Mark approval for its IntelliFlex Low
Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2013, Lombard Medical
Inc. launched its Aorfix, a latest endovascular stent graft in the U.S. market. In 2014, Cordis
Corporation (now a part of Cardinal Health, Inc.) launched its INCRAFT AAA Stent Graft System
(INCRAFT System), a device for use during endovascular aneurysm repair (EVAR) for patients
suffering from infrarenal AAA. In 2015, Endologix, Inc. received approval from the Japanese
Ministry of Health, Labour and Welfare (MHLW) for its AFX Endovascular AAA System for the
treatment of abdominal aortic aneurysms. In 2014, Medtronic Plc. received approval for its new
Endurant IIs in the U.S. and Europe. Endurant IIs is a latest stent graft system for the
endovascular repair of abdominal aortic aneurysms. These approvals have led to development of
novel products in the market, which is expected to drive growth of global abdominal aortic
aneurysm repair devices market in the near future. Increasing collaborations and acquisition
activities by key players in market is also expected to support growth of global abdominal